Shenzhu Pingxiao formula treats allergic asthma through the HSP90AA1/MAPK14/PTGS2 pathway

Shenzhu Pingxiao formula can reduce neutrophil recruitment and exert anti-AA effects via suppression of HSP90AA1/MAPK14/PTGS2 pathway.

Authors

Xiaoxia Zhang (ORCID: https://orcid.org/0000-0002-4580-493X)
Jinling Luan

Institutions

Tongde Hospital of Zhejiang Province (CN)

Publication Details

Journal: Journal of Asthma
Published: 2025-09-26
DOI: https://doi.org/10.1080/02770903.2025.2562582
Primary Topic: Asthma and respiratory diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Shenzhu Pingxiao formula treats allergic asthma through the HSP90AA1/MAPK14/PTGS2 pathway

Xiaoxia Zhang, Jinling Luan

Sep 26, 2025

Journal of Asthma

Asthma and respiratory diseases

article

Shenzhu Pingxiao formula treats allergic asthma through the HSP90AA1/MAPK14/PTGS2 pathway

Xiaoxia Zhang, Jinling Luan

September 26, 2025article en

Abstract

Shenzhu Pingxiao formula can reduce neutrophil recruitment and exert anti-AA effects via suppression of HSP90AA1/MAPK14/PTGS2 pathway.

Journal of AsthmaVol. 63(1)

Tongde Hospital of Zhejiang Province (CN)

Openalex Percentile: Top 67%

Asthma and respiratory diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Shenzhu Pingxiao formula treats allergic asthma through the HSP90AA1/MAPK14/PTGS2 pathway — Xiaoxia Zhang, Jinling Luan · Journal of Asthma (2025) | TGRS Research Map | TGRS